Target Name: RND2
NCBI ID: G8153
Review Report on RND2 Target / Biomarker Content of Review Report on RND2 Target / Biomarker
RND2
Other Name(s): GTP-binding protein Rho7 | ras homolog gene family, member N | ARHN | CTD-3199J23.4 | RHO7 | RhoN | Rho-related GTP-binding protein Rho7 | Ras homolog gene family, member N | Rho-related GTP-binding protein RhoN | Rho7 | Rnd2 | RND2_HUMAN | Rho family GTPase 2 | rho-related GTP-binding protein Rho7

Overview of GTP-Binding Protein Rho7

GTP-binding proteins, or Rho proteins, are a family of molecular motors that play a central role in cell signaling. These proteins are involved in various cellular processes, including cell division, cytoskeletal organization, and vesicle traffic. GTP-binding proteins are also known as HSP70 proteins, named after their human homolog protein, heat shock protein 70.

One of the most well-known GTP-binding proteins is Rho7, also known as GTP-binding protein Rho7. Rho7 is a 21-kDa protein that is expressed in various cell types, including muscle, heart, and brain cells. Rho7 is involved in various cellular processes that require the use of GTP, such as cell signaling, cytoskeletal organization, and vesicle traffic.

Rho7 is a protein that is highly conserved across various species, including humans. It has a unique structure that is composed of a catalytic domain, a transmembrane region, and an N-terminus. The catalytic domain is the region of the protein that contains the GTP-binding affinity, while the transmembrane region is responsible for the protein's trafficking and localization to the cytoskeleton. The N-terminus is the region of the protein that interacts with other proteins and molecules.

Rho7 is involved in various cellular processes that require the use of GTP, such as cell signaling, cytoskeletal organization, and vesicle traffic. One of the most well-known functions of Rho7 is its role in cell signaling. Rho7 is involved in the regulation of cell proliferation, differentiation, and survival. It is also involved in the regulation of cell migration, and in the regulation of cell-cell and cell-tissue interactions.

In addition to its role in cell signaling, Rho7 is also involved in the regulation of cytoskeletal organization. Rho7 is a member of the Rho GTPase family, which is involved in the regulation of cytoskeletal organization. Rho7 is involved in the formation of microtubules, which are the protein scaffolds that provide the structure for the cytoskeleton. Rho7 is also involved in the regulation of actin dynamics, which are the processes that regulate the movement of cells.

Rho7 is also involved in the regulation of vesicle traffic. Vesicle traffic refers to the movement of small packets of RNA and proteins from the cytoplasm to the cell nucleus. Rho7 is involved in the regulation of vesicle traffic, including the movement of the protein translocation-associated protein (TAP) to the endoplasmic reticulum.

In conclusion, Rho7 is a GTP-binding protein that is involved in various cellular processes, including cell signaling, cytoskeletal organization, and vesicle traffic. Its functions are crucial for the proper functioning of cells, and Rho7 is a potential drug target and biomarker for various diseases.

Protein Name: Rho Family GTPase 2

Functions: May be specifically involved in neuronal and hepatic functions. Is a C3 toxin-insensitive member of the Rho subfamily (By similarity)

The "RND2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RND2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RND3 | RNF10 | RNF103 | RNF103-CHMP3 | RNF11 | RNF111 | RNF112 | RNF113A | RNF113B | RNF114 | RNF115 | RNF121 | RNF122 | RNF123 | RNF125 | RNF126 | RNF126P1 | RNF128 | RNF13 | RNF130 | RNF133 | RNF135 | RNF138 | RNF138P1 | RNF139 | RNF139-DT | RNF14 | RNF141 | RNF144A | RNF144B | RNF145 | RNF146 | RNF148 | RNF149 | RNF150 | RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181 | RNF182 | RNF183 | RNF185 | RNF186 | RNF187 | RNF19A | RNF19B | RNF2 | RNF20 | RNF207 | RNF208 | RNF212 | RNF212B | RNF213 | RNF213-AS1 | RNF214 | RNF215 | RNF216 | RNF216-IT1 | RNF216P1 | RNF217 | RNF217-AS1 | RNF220 | RNF222 | RNF224 | RNF225 | RNF227 | RNF24 | RNF25 | RNF26 | RNF31 | RNF32 | RNF32-DT | RNF34 | RNF38 | RNF39 | RNF4 | RNF40 | RNF41 | RNF43 | RNF44 | RNF5 | RNF5P1 | RNF6 | RNF7 | RNF7P1 | RNF8 | RNFT1 | RNFT2 | RNGTT | RNH1